Blood Pressure and Development of Cardiovascular Disease in Koreans With Type 2 Diabetes Mellitus
The objective of this study was to investigate the optimal blood pressure (BP) target to prevent development of cardiovascular diseases (CVDs) in Korean subjects with type 2 diabetes mellitus. Using the Korean National Health Insurance Service database, 2 262 725 subjects with type 2 diabetes mellit...
Saved in:
Published in | Hypertension (Dallas, Tex. 1979) Vol. 73; no. 2; pp. 319 - 326 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Heart Association, Inc
01.02.2019
|
Subjects | |
Online Access | Get full text |
ISSN | 0194-911X 1524-4563 1524-4563 |
DOI | 10.1161/HYPERTENSIONAHA.118.12160 |
Cover
Abstract | The objective of this study was to investigate the optimal blood pressure (BP) target to prevent development of cardiovascular diseases (CVDs) in Korean subjects with type 2 diabetes mellitus. Using the Korean National Health Insurance Service database, 2 262 725 subjects with type 2 diabetes mellitus who underwent regular health checks between 2009 and 2012 were included. Subjects with previous CVDs were excluded. Participants were grouped by 10-mm Hg intervals of observed systolic BP (SBP) by 5-mm Hg intervals of diastolic BP. There were 124 466 deaths (5.50%), 67 235 cases of stroke (2.97%), and 41 726 myocardial infarctions (1.84%) during a median follow-up of 6.5 years. Compared with SBP 110 to 119 mm Hg, there was no increased risk among subjects with SBP 120 to 129 mm Hg, but SBP ≥130 mm Hg was associated with a significant increase in the incidence of CVDs. SBP 130 to 139 mm Hg was associated with a significant increase in the incidence of stroke (hazard ratio, 1.15; 95% CI, 1.12–1.18) and myocardial infarctions (hazard ratio, 1.05; 95% CI, 1.02–1.09) compared with SBP 110 to 119 mm Hg. Subjects with diastolic BP 80 to 84 mm Hg had a higher risk of CVDs than subjects with diastolic BP 75 to 79 mm Hg. The overall relationship between BP and CVD risk was positive, with a greater strength observed for younger age groups. The optimal cutoff for Korean patients with type 2 diabetes mellitus associated with lower CVD risk may be 130 mm Hg for SBP or 80 mm Hg for diastolic BP. |
---|---|
AbstractList | The objective of this study was to investigate the optimal blood pressure (BP) target to prevent development of cardiovascular diseases (CVDs) in Korean subjects with type 2 diabetes mellitus. Using the Korean National Health Insurance Service database, 2 262 725 subjects with type 2 diabetes mellitus who underwent regular health checks between 2009 and 2012 were included. Subjects with previous CVDs were excluded. Participants were grouped by 10-mm Hg intervals of observed systolic BP (SBP) by 5-mm Hg intervals of diastolic BP. There were 124 466 deaths (5.50%), 67 235 cases of stroke (2.97%), and 41 726 myocardial infarctions (1.84%) during a median follow-up of 6.5 years. Compared with SBP 110 to 119 mm Hg, there was no increased risk among subjects with SBP 120 to 129 mm Hg, but SBP ≥130 mm Hg was associated with a significant increase in the incidence of CVDs. SBP 130 to 139 mm Hg was associated with a significant increase in the incidence of stroke (hazard ratio, 1.15; 95% CI, 1.12–1.18) and myocardial infarctions (hazard ratio, 1.05; 95% CI, 1.02–1.09) compared with SBP 110 to 119 mm Hg. Subjects with diastolic BP 80 to 84 mm Hg had a higher risk of CVDs than subjects with diastolic BP 75 to 79 mm Hg. The overall relationship between BP and CVD risk was positive, with a greater strength observed for younger age groups. The optimal cutoff for Korean patients with type 2 diabetes mellitus associated with lower CVD risk may be 130 mm Hg for SBP or 80 mm Hg for diastolic BP. The objective of this study was to investigate the optimal blood pressure (BP) target to prevent development of cardiovascular diseases (CVDs) in Korean subjects with type 2 diabetes mellitus. Using the Korean National Health Insurance Service database, 2 262 725 subjects with type 2 diabetes mellitus who underwent regular health checks between 2009 and 2012 were included. Subjects with previous CVDs were excluded. Participants were grouped by 10-mm Hg intervals of observed systolic BP (SBP) by 5-mm Hg intervals of diastolic BP. There were 124 466 deaths (5.50%), 67 235 cases of stroke (2.97%), and 41 726 myocardial infarctions (1.84%) during a median follow-up of 6.5 years. Compared with SBP 110 to 119 mm Hg, there was no increased risk among subjects with SBP 120 to 129 mm Hg, but SBP ≥130 mm Hg was associated with a significant increase in the incidence of CVDs. SBP 130 to 139 mm Hg was associated with a significant increase in the incidence of stroke (hazard ratio, 1.15; 95% CI, 1.12-1.18) and myocardial infarctions (hazard ratio, 1.05; 95% CI, 1.02-1.09) compared with SBP 110 to 119 mm Hg. Subjects with diastolic BP 80 to 84 mm Hg had a higher risk of CVDs than subjects with diastolic BP 75 to 79 mm Hg. The overall relationship between BP and CVD risk was positive, with a greater strength observed for younger age groups. The optimal cutoff for Korean patients with type 2 diabetes mellitus associated with lower CVD risk may be 130 mm Hg for SBP or 80 mm Hg for diastolic BP.The objective of this study was to investigate the optimal blood pressure (BP) target to prevent development of cardiovascular diseases (CVDs) in Korean subjects with type 2 diabetes mellitus. Using the Korean National Health Insurance Service database, 2 262 725 subjects with type 2 diabetes mellitus who underwent regular health checks between 2009 and 2012 were included. Subjects with previous CVDs were excluded. Participants were grouped by 10-mm Hg intervals of observed systolic BP (SBP) by 5-mm Hg intervals of diastolic BP. There were 124 466 deaths (5.50%), 67 235 cases of stroke (2.97%), and 41 726 myocardial infarctions (1.84%) during a median follow-up of 6.5 years. Compared with SBP 110 to 119 mm Hg, there was no increased risk among subjects with SBP 120 to 129 mm Hg, but SBP ≥130 mm Hg was associated with a significant increase in the incidence of CVDs. SBP 130 to 139 mm Hg was associated with a significant increase in the incidence of stroke (hazard ratio, 1.15; 95% CI, 1.12-1.18) and myocardial infarctions (hazard ratio, 1.05; 95% CI, 1.02-1.09) compared with SBP 110 to 119 mm Hg. Subjects with diastolic BP 80 to 84 mm Hg had a higher risk of CVDs than subjects with diastolic BP 75 to 79 mm Hg. The overall relationship between BP and CVD risk was positive, with a greater strength observed for younger age groups. The optimal cutoff for Korean patients with type 2 diabetes mellitus associated with lower CVD risk may be 130 mm Hg for SBP or 80 mm Hg for diastolic BP. |
Author | Kim, Mee Kyoung Han, Kyungdo Nam, Ga Eun Koh, Eun Sil Kim, Eun Sook Lee, Min-Kyung Kwon, Hyuk-Sang |
AuthorAffiliation | From the Division of Endocrinology and Metabolism, Department of Internal Medicine, Yeouido St. Mary’s Hospital (M.K.K., H.-S.K.), College of Medicine, Catholic University of Korea, Seoul Department of Medical Statistics (K.H.), College of Medicine, Catholic University of Korea, Seoul Division of Nephrology, Department of Internal Medicine, Yeouido St. Mary’s Hospital (E.S. Koh), College of Medicine, Catholic University of Korea, Seoul Division of Endocrinology and Metabolism, Department of Internal Medicine, Incheon St. Mary’s Hospital (E.S. Kim), College of Medicine, Catholic University of Korea, Seoul Division of Endocrinology and Metabolism, Department of Internal Medicine, Myongji Hospital, Hanyang University Medical Center, Goyang-Si, Korea (M.-K.L.) Department of Family Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul (G.E.N.) |
AuthorAffiliation_xml | – name: From the Division of Endocrinology and Metabolism, Department of Internal Medicine, Yeouido St. Mary’s Hospital (M.K.K., H.-S.K.), College of Medicine, Catholic University of Korea, Seoul Department of Medical Statistics (K.H.), College of Medicine, Catholic University of Korea, Seoul Division of Nephrology, Department of Internal Medicine, Yeouido St. Mary’s Hospital (E.S. Koh), College of Medicine, Catholic University of Korea, Seoul Division of Endocrinology and Metabolism, Department of Internal Medicine, Incheon St. Mary’s Hospital (E.S. Kim), College of Medicine, Catholic University of Korea, Seoul Division of Endocrinology and Metabolism, Department of Internal Medicine, Myongji Hospital, Hanyang University Medical Center, Goyang-Si, Korea (M.-K.L.) Department of Family Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul (G.E.N.) – name: From the Division of Endocrinology and Metabolism, Department of Internal Medicine, Yeouido St. Mary’s Hospital, College of Medicine, Catholic University of Korea, Seoul (M.K.K., H.-S.K.) Department of Medical Statistics, College of Medicine, Catholic University of Korea, Seoul (K.H.) Division of Nephrology, Department of Internal Medicine, Yeouido St. Mary’s Hospital, College of Medicine, Catholic University of Korea, Seoul (E.S. Koh) Division of Endocrinology and Metabolism, Department of Internal Medicine, Incheon St. Mary’s Hospital, College of Medicine, Catholic University of Korea, Seoul (E.S. Kim) Division of Endocrinology and Metabolism, Department of Internal Medicine, Myongji Hospital, Hanyang University Medical Center, Goyang-Si, Korea (M.-K.L.) Department of Family Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul (G.E.N.) |
Author_xml | – sequence: 1 givenname: Mee surname: Kim middlename: Kyoung fullname: Kim, Mee Kyoung organization: From the Division of Endocrinology and Metabolism, Department of Internal Medicine, Yeouido St. Mary’s Hospital (M.K.K., H.-S.K.), College of Medicine, Catholic University of Korea, Seoul Department of Medical Statistics (K.H.), College of Medicine, Catholic University of Korea, Seoul Division of Nephrology, Department of Internal Medicine, Yeouido St. Mary’s Hospital (E.S. Koh), College of Medicine, Catholic University of Korea, Seoul Division of Endocrinology and Metabolism, Department of Internal Medicine, Incheon St. Mary’s Hospital (E.S. Kim), College of Medicine, Catholic University of Korea, Seoul Division of Endocrinology and Metabolism, Department of Internal Medicine, Myongji Hospital, Hanyang University Medical Center, Goyang-Si, Korea (M.-K.L.) Department of Family Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul (G.E.N.) – sequence: 2 givenname: Kyungdo surname: Han fullname: Han, Kyungdo – sequence: 3 givenname: Eun surname: Koh middlename: Sil fullname: Koh, Eun Sil – sequence: 4 givenname: Eun surname: Kim middlename: Sook fullname: Kim, Eun Sook – sequence: 5 givenname: Min-Kyung surname: Lee fullname: Lee, Min-Kyung – sequence: 6 givenname: Ga surname: Nam middlename: Eun fullname: Nam, Ga Eun – sequence: 7 givenname: Hyuk-Sang surname: Kwon fullname: Kwon, Hyuk-Sang |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30624985$$D View this record in MEDLINE/PubMed |
BookMark | eNqNUk1P3DAQtSpQWWj_QuXeegn4K05yqKpl2bKoFBBs1fZkOclY69Ybb20HxL-vy8KFQ4WlkTXj996M5nkf7Qx-AITeU3JIqaRHi59X8-vl_OLm7PJiupjmYn1IGZXkFZrQkolClJLvoAmhjSgaSn_sof0YfxFChRDVa7THiWSiqcsJ0sfO-x5fBYhxDID10OMTuAXnN2sYEvYGz3Torb_VsRudDvjERtARsB3wFx9ADxF_t2mFl_cbwCw_6xYSRPwVnLNpjG_QrtEuwtvH-wB9-zxfzhbF-eXp2Wx6XnQiT140rJWVqXnPqWk62rSSMtDG9G2vGRBumClNU1V9zUxHGNBSdqTtuOC9MFxKfoA-bHU3wf8ZISa1trHLQ-gB_BgVo1XDWVnVPEPfPULHdg292gS71uFePa0lAz5tAV3wMQYwqrNJJ-uHFLR1ihL1zwj1zIhcrNWDEVmheabw1OQl3I9b7p13CUL87cY7CGoF2qXVi_jiP3ySj2CyLlj-HoTlrMhBJf8LLLey6g |
CitedBy_id | crossref_primary_10_2147_RMHP_S385815 crossref_primary_10_1186_s12933_019_0953_7 crossref_primary_10_4070_kcj_2020_0171 crossref_primary_10_1002_jhbp_12109 crossref_primary_10_1089_thy_2019_0543 crossref_primary_10_1161_HYPERTENSIONAHA_120_15320 crossref_primary_10_1161_JAHA_123_030772 crossref_primary_10_1007_s15006_019_0707_1 crossref_primary_10_1097_PRS_0000000000011297 crossref_primary_10_1111_jdi_13539 crossref_primary_10_4078_jrd_2023_0011 crossref_primary_10_4093_dmj_2019_0137 crossref_primary_10_1161_JAHA_120_017475 crossref_primary_10_1186_s12933_022_01705_3 crossref_primary_10_1161_CIRCEP_119_007428 crossref_primary_10_1038_s41366_021_00922_2 crossref_primary_10_12997_jla_2021_10_3_303 crossref_primary_10_1007_s15027_019_1544_y crossref_primary_10_1016_j_jocn_2024_03_004 crossref_primary_10_4093_jkd_2020_21_1_27 crossref_primary_10_1097_HJH_0000000000002980 crossref_primary_10_1016_j_diabres_2020_108157 crossref_primary_10_1038_s41598_021_81328_y crossref_primary_10_1186_s12933_019_0943_9 crossref_primary_10_1016_j_lanwpc_2020_100085 crossref_primary_10_1161_JAHA_120_017783 crossref_primary_10_1111_dom_15710 crossref_primary_10_1038_s41598_024_51757_6 crossref_primary_10_1371_journal_pone_0299035 crossref_primary_10_3346_jkms_2020_35_e312 crossref_primary_10_1371_journal_pone_0262757 |
Cites_doi | 10.1111/jdi.12810 10.1093/eurheartj/ehx585 10.1002/sim.7144 10.4070/kcj.2017.0036 10.1001/jamacardio.2016.2861 10.1111/jch.12009 10.1097/01.hjh.0000431740.32696.cc 10.1097/01.hjh.0000052492.18130.07 10.3803/EnM.2014.29.4.405 10.1258/0004563054889936 10.1161/01.ATV.0000160548.78317.29 10.1161/01.CIR.100.4.354 10.1001/jama.2014.18574 10.1056/NEJMoa1511939 10.1161/HYPERTENSIONAHA.117.10034 10.1253/circj.CJ-13-0786 10.1016/j.amjhyper.2005.06.024 10.2337/dc18-S009 10.4093/dmj.2018.42.2.93 10.1161/HYPERTENSIONAHA.111.00289 10.2337/dc17-2443 10.3803/EnM.2015.30.4.522 10.1001/archinte.167.19.2139 10.1016/S2213-8587(17)30327-3 10.4093/dmj.2016.40.1.79 10.1291/hypres.31.2115 10.1056/NEJM200006223422506 10.1161/01.hyp.23.3.395 10.2337/dc17-1366 |
ContentType | Journal Article |
Copyright | 2019 American Heart Association, Inc 2018 American Heart Association, Inc |
Copyright_xml | – notice: 2019 American Heart Association, Inc – notice: 2018 American Heart Association, Inc |
DBID | AAYXX CITATION NPM 7X8 |
DOI | 10.1161/HYPERTENSIONAHA.118.12160 |
DatabaseName | CrossRef PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | CrossRef PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1524-4563 |
EndPage | 326 |
ExternalDocumentID | 30624985 10_1161_HYPERTENSIONAHA_118_12160 10.1161/HYPERTENSIONAHA.118.12160 00004268-201902000-00016 |
Genre | Journal Article |
GroupedDBID | --- .-D .3C .55 .GJ .XZ .Z2 01R 0R~ 18M 1J1 2WC 3O- 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 71W 77Y 7O~ AAAAV AAAXR AAFWJ AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AARTV AASCR AASOK AAXQO AAYEP ABASU ABBUW ABDIG ABJNI ABOCM ABPXF ABQRW ABVCZ ABXVJ ABXYN ABZAD ABZZY ACCJW ACDDN ACEWG ACGFO ACGFS ACILI ACLDA ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADFPA ADGGA ADHPY ADNKB AE3 AE6 AEBDS AEETU AENEX AFBFQ AFDTB AFEXH AFFNX AFNMH AFUWQ AGINI AHMBA AHOMT AHQNM AHQVU AHRYX AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJNYG AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BAWUL BCGUY BOYCO BQLVK BS7 C1A C45 CS3 DIK DIWNM DUNZO E.X E3Z EBS EEVPB EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- FW0 GNXGY GQDEL GX1 H0~ H13 HLJTE HZ~ IKREB IKYAY IN~ IPNFZ JF9 JG8 JK3 JK8 K-A K-F K8S KD2 KMI KQ8 L-C L7B N4W N9A N~7 N~B N~M O9- OAG OAH OB3 OCUKA ODA ODMTH OGROG OHYEH OK1 OL1 OLG OLH OLU OLV OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P PQQKQ R58 RAH RIG RLZ S4R S4S T8P TEORI TR2 TSPGW V2I VVN W3M W8F WH7 WOQ WOW X3V X3W X7M XXN XYM YFH YHZ YOC YYM YYP ZFV ZGI ZZMQN AAYXX ADGHP ADKSD ADSXY CITATION OZ- ACIJW AWKKM NPM OLW RHF 7X8 |
ID | FETCH-LOGICAL-c4160-92b67f83d31f9c19b612eaffdbda2e03f2f5f977d82fc02e156c0bc343d4f3663 |
ISSN | 0194-911X 1524-4563 |
IngestDate | Mon Sep 08 07:17:08 EDT 2025 Wed Feb 19 02:34:25 EST 2025 Wed Oct 01 02:26:28 EDT 2025 Thu Apr 24 22:56:08 EDT 2025 Fri May 16 03:57:17 EDT 2025 Fri May 16 04:02:50 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | blood pressure diabetes mellitus cardiovascular diseases hypertension Korea |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4160-92b67f83d31f9c19b612eaffdbda2e03f2f5f977d82fc02e156c0bc343d4f3663 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 30624985 |
PQID | 2179325783 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_2179325783 pubmed_primary_30624985 crossref_citationtrail_10_1161_HYPERTENSIONAHA_118_12160 crossref_primary_10_1161_HYPERTENSIONAHA_118_12160 wolterskluwer_health_10_1161_HYPERTENSIONAHA_118_12160 wolterskluwer_health_00004268-201902000-00016 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-February |
PublicationDateYYYYMMDD | 2019-02-01 |
PublicationDate_xml | – month: 02 year: 2019 text: 2019-February |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Hypertension (Dallas, Tex. 1979) |
PublicationTitleAlternate | Hypertension |
PublicationYear | 2019 |
Publisher | American Heart Association, Inc |
Publisher_xml | – name: American Heart Association, Inc |
References | e_1_3_4_3_2 e_1_3_4_2_2 e_1_3_4_9_2 e_1_3_4_8_2 e_1_3_4_7_2 e_1_3_4_6_2 e_1_3_4_5_2 e_1_3_4_4_2 e_1_3_4_22_2 e_1_3_4_23_2 e_1_3_4_20_2 e_1_3_4_21_2 e_1_3_4_26_2 e_1_3_4_27_2 e_1_3_4_24_2 e_1_3_4_25_2 e_1_3_4_28_2 e_1_3_4_29_2 National Kidney Foundation (e_1_3_4_15_2) 2002; 39 e_1_3_4_30_2 e_1_3_4_11_2 e_1_3_4_12_2 e_1_3_4_10_2 e_1_3_4_31_2 e_1_3_4_16_2 e_1_3_4_13_2 e_1_3_4_14_2 e_1_3_4_19_2 e_1_3_4_17_2 e_1_3_4_18_2 |
References_xml | – ident: e_1_3_4_31_2 doi: 10.1111/jdi.12810 – ident: e_1_3_4_11_2 doi: 10.1093/eurheartj/ehx585 – ident: e_1_3_4_25_2 doi: 10.1002/sim.7144 – ident: e_1_3_4_26_2 doi: 10.4070/kcj.2017.0036 – ident: e_1_3_4_8_2 doi: 10.1001/jamacardio.2016.2861 – ident: e_1_3_4_27_2 doi: 10.1111/jch.12009 – ident: e_1_3_4_3_2 doi: 10.1097/01.hjh.0000431740.32696.cc – ident: e_1_3_4_18_2 doi: 10.1097/01.hjh.0000052492.18130.07 – ident: e_1_3_4_12_2 doi: 10.3803/EnM.2014.29.4.405 – ident: e_1_3_4_14_2 doi: 10.1258/0004563054889936 – ident: e_1_3_4_22_2 doi: 10.1161/01.ATV.0000160548.78317.29 – ident: e_1_3_4_23_2 doi: 10.1161/01.CIR.100.4.354 – ident: e_1_3_4_30_2 doi: 10.1001/jama.2014.18574 – ident: e_1_3_4_4_2 doi: 10.1056/NEJMoa1511939 – ident: e_1_3_4_17_2 doi: 10.1161/HYPERTENSIONAHA.117.10034 – ident: e_1_3_4_19_2 doi: 10.1253/circj.CJ-13-0786 – ident: e_1_3_4_20_2 doi: 10.1016/j.amjhyper.2005.06.024 – ident: e_1_3_4_2_2 doi: 10.2337/dc18-S009 – ident: e_1_3_4_9_2 doi: 10.4093/dmj.2018.42.2.93 – ident: e_1_3_4_29_2 doi: 10.1161/HYPERTENSIONAHA.111.00289 – ident: e_1_3_4_16_2 doi: 10.2337/dc17-2443 – ident: e_1_3_4_13_2 doi: 10.3803/EnM.2015.30.4.522 – ident: e_1_3_4_28_2 doi: 10.1001/archinte.167.19.2139 – volume: 39 start-page: S1 year: 2002 ident: e_1_3_4_15_2 article-title: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. publication-title: Am J Kidney Dis – ident: e_1_3_4_6_2 doi: 10.1016/S2213-8587(17)30327-3 – ident: e_1_3_4_10_2 doi: 10.4093/dmj.2016.40.1.79 – ident: e_1_3_4_21_2 doi: 10.1291/hypres.31.2115 – ident: e_1_3_4_7_2 doi: 10.1056/NEJM200006223422506 – ident: e_1_3_4_24_2 doi: 10.1161/01.hyp.23.3.395 – ident: e_1_3_4_5_2 doi: 10.2337/dc17-1366 |
SSID | ssj0014447 |
Score | 2.4470963 |
Snippet | The objective of this study was to investigate the optimal blood pressure (BP) target to prevent development of cardiovascular diseases (CVDs) in Korean... |
SourceID | proquest pubmed crossref wolterskluwer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 319 |
Title | Blood Pressure and Development of Cardiovascular Disease in Koreans With Type 2 Diabetes Mellitus |
URI | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00004268-201902000-00016 https://www.ncbi.nlm.nih.gov/pubmed/30624985 https://www.proquest.com/docview/2179325783 |
Volume | 73 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1524-4563 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0014447 issn: 0194-911X databaseCode: KQ8 dateStart: 19790101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1524-4563 dateEnd: 20241003 omitProxy: true ssIdentifier: ssj0014447 issn: 0194-911X databaseCode: DIK dateStart: 19790101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1524-4563 dateEnd: 20241003 omitProxy: true ssIdentifier: ssj0014447 issn: 0194-911X databaseCode: GX1 dateStart: 19790101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZZB2VjjN2X3VBhb8GdLcmy_JgtHWYhZYMUsidjyxItG_ZoHbbu9-yH7ujixGla1u7FGKGL0fl8bjpHB6G3ZQFiRCZgqeq0CFiqWFAk1m8lQkpjUUlbh2x2yLMj9mkRLwaDP72opWVb7svfl-aV_A9VoQ3oarJkb0DZ1aTQAO9AX3gCheF5LRq_N1HnPsPPnwP0goBc6tVGuOnEHccYJ8e0AXWxNuGv7fFo7hyxk84ROzPXdLbeJ-BV1wz6nNp4dwsYMTEueBdkpH7tj6I0SXtuBV-leabUaHpuOMqa1Vk-Nz2HtqpZdW-OXdoNcJt10IefxLZ2xoD3UJikqM1oj-7oKYN_t-3DbivcEwYzw34Xff7sSp14HJIes6We2Tq5TV3m_bZI4EYkZF8_H4CBcGgk1DgbQ7MwF2u4WgYXbty2dhPhBmugLnW59xG_hW6ThHNTJ2P6ZX1WxRjzSfnu23fRnl_33ZWrbmpBW6bNXXTvZ2OiJc6-2WSJnsozf4Due1sFjx3wHqKBqh-h3ZmPxniMCos_3OEPA_5wD3-40XgTf9jjD5_U2OMPG_xhgz9McIc_3OHvCTr6eDD_kAW-ZEcgQbMPg5SUPNGCVjTSqYzSEhRoVWhdlVVBVEg10bEGk6MSRMuQqCjmMiwlZbRimoL2-xTt1E2tniMsSi2rmOo4SjjToNcC40hFEcYyobKg6RCJbgtz6e-zN2VVvufWruVRfmH3oVHkdveHiKyG_nCXulxn0F5HpxxYsDlXK2rVLM9yYoScEX10iJ45Aq6mBYucsFTEQxRsUDR3ac75VVgbIn5p_39-5osbLvQS3Vn_s6_QTnu6VK9Bz27LNxbmfwHQpMeT |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Blood+Pressure+and+Development+of+Cardiovascular+Disease+in+Koreans+With+Type+2+Diabetes+Mellitus&rft.jtitle=Hypertension+%28Dallas%2C+Tex.+1979%29&rft.au=Kim%2C+Mee+Kyoung&rft.au=Han%2C+Kyungdo&rft.au=Koh%2C+Eun+Sil&rft.au=Kim%2C+Eun+Sook&rft.date=2019-02-01&rft.pub=American+Heart+Association%2C+Inc&rft.issn=0194-911X&rft.volume=73&rft.issue=2&rft.spage=319&rft.epage=326&rft_id=info:doi/10.1161%2FHYPERTENSIONAHA.118.12160&rft.externalDocID=00004268-201902000-00016 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0194-911X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0194-911X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0194-911X&client=summon |